Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Marisiensis - Seria Medica
Volume 63 (2017): Issue 2 (June 2017)
Open Access
The Influence of CYP2D6 Phenotype on the Pharmacokinetic Profile of Atomoxetine in Caucasian Healthy Subjects
Ioana Todor
Ioana Todor
,
Dana Muntean
Dana Muntean
,
Maria Neag
Maria Neag
,
Corina Bocsan
Corina Bocsan
,
Anca Buzoianu
Anca Buzoianu
,
Laurian Vlase
Laurian Vlase
,
Daniel Leucuta
Daniel Leucuta
,
Ana-Maria Gheldiu
Ana-Maria Gheldiu
,
Adina Popa
Adina Popa
and
Corina Briciu
Corina Briciu
| Jul 08, 2017
Acta Marisiensis - Seria Medica
Volume 63 (2017): Issue 2 (June 2017)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Research Article
Published Online:
Jul 08, 2017
Page range:
73 - 79
Received:
May 28, 2017
Accepted:
Jun 20, 2017
DOI:
https://doi.org/10.1515/amma-2017-0023
Keywords
atomoxetine
,
4 hydroxyatomoxetine O glucuronide
,
phenotype
,
metabolic ratio
,
pharmacokinetics
© by Laurian Vlase
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.